Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

Outsourcing about cost reduction more than anything else says Deloitte

Drug companies still outsource to make fixed costs variable rather than to improve their public profiles according to a Deloitte analyst.

Sterigenics invests $15m in Arkansas gamma sterilisation site

Sterigenics will triple gamma sterilisation capacity at a site in Arkansas on the back of strong demand from pharmaceutical and medical device customers.

‘First liquid aspirin’ maker seeks licensing deal

Innovate Pharmaceuticals has launched what it claims is the world’s first shelf-stable liquid aspirin, and says it is on the look-out for a licensing partner for the “$500m” market.

Pharma outsourcing more med affairs and post approval work say experts

Medical affairs and post-market research are fast growing opportunities for CROs according to observers who say drug companies are starting to outsource more late-phase and post approval work.

Johnson Matthey to take on all Pharmorphix staff

Johnson Matthey buys Sigma-Aldrich solid state chem unit to boost API business

Johnson Matthey has bought Sigma-Aldrich’s Pharmorphix division to add a 'significant' customer base and expand its European API business.

Vetter pledges €300m to prep network for pharma's future needs

Pharma M&A, complex APIs and an increasing need for flexibility are driving a €300m manufacturing network overhaul, says Vetter.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...